Facing increasing pressure from the U.S. Government, JUUL Labs, the leading manufacturer of e-cigarette products, recently announced it would stop selling mint-flavored pods. This announcement came after the company previously stopped selling fruit- and dessert-flavored pods like mango and crème brû
While Zantac (ranitidine) manufacturer Sanofi maintains that its product is safe, Australian drug regulators recently announced that three-quarters of the ranitidine samples they tested contained high levels of N-nitrosodimethylamine (NDMA), a probable human carcinogen. Sanofi recently recalled Zant
Amidst investigations of Zantac (ranitidine) contamination with probable carcinogen N- Nitrosodimethylamine (NDMA), more companies are pulling their products from the market. The Food and Drug Administration (FDA) has notified the public of each of these recalls as they’ve occurred. The first few re
Amidst rising concerns that some medications may be contaminated with a potential cancer-causing agent, Zantac manufacturer Sanofi recently announced a recall of the heartburn medication in both the United States and Canada. The company stated it was initiating a voluntary recall “as a precautionary
The FDA recently announced a Class I recall of about 25,000 GE Healthcare Giraffe Infant Warmers and Panda i-Res Infant Warmers due to safety concerns. A Class I recall is the most serious type of recall and identifies devices that may cause serious injuries or…
Vehicle airbag problems are in the news once again. According to Consumer Reports, Volkswagen (VW) is recalling over 27,000 vehicles because of airbag deployment issues that could increase the risk of a crash. Consumers are advised to take their vehicles to a VW dealer for…
On March 8, 2019, the FDA sent a letter to health care providers because of concerns regarding an increasing number of adverse events associated with surgical staplers. From January 1, 2011, to March 31, 2018, the FDA received over 41,000 individual medical device reports for…
According to a recent report by the Centers for Medicare and Medicaid Services (CMS), doctors and hospitals received even more money in 2018 from pharmaceutical and medical device manufacturers than they did in 2017. These payments were for things like doctor speaking and consulting fees,…
After suffering losses in three key Roundup cancer lawsuits, manufacturer Bayer recently announced its plans to investigate an alternative to glyphosate, the main herbicide in Roundup. In a June 2019 statement, the company revealed that it would invest about 5 billion Euros “in additional methods…
Manufacturer Monsanto and parent company Bayer are currently facing thousands of lawsuits filed by plaintiffs who claim to have developed non-Hodgkin’s lymphoma after using the herbicide Roundup for extended periods of time. Several studies have linked Roundup and its main ingredient glyphosate to n
In May 2019, the FDA warned doctors and patients about potential problems linked to textured breast implants. Amy Abernethy, FDA Principal Deputy Commissioner, and Jeff Shuren, Director of the FDA’s Center for Devices and Radiological Health, released a joint statement in which they acknowledged the
In May 2019, a California jury handed down a $2 billion verdict in the third Roundup trial to result in a plaintiffs’ verdict. The couple who brought the lawsuit claimed they developed cancer after using the weed killer and its active herbicide glyphosate for many…
